drugset / Trial / NCT00983034

The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy

NCT00983034

Completed 70 enrolled Istanbul University
RandomizedParallel-groupOpen-labelSupportive care

Summary

Membranous nephropathy (MN) may also be secondary to many other diseases (e.g., infections, drugs, neoplasms and autoimmune diseases). In this study, the presence of Helicobacter Pylori (H. pylori) antigen was investigated in renal tissue from needle biopsy samples, and the prevalence of H. pylori infection and the effects of H. pylori eradication on proteinuria level in patients with MN will be investigated.

Timeline

Start
2006-03
Primary completion
2008-12
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 0.75 g
Comparator Clarithromycin Small molecule 250 mg
Comparator Lansoprazole Other / unclassified 30 mg